Introduction
Apoptosis (Wyllie, 1987) is one form of cellular suicide that occurs widely during normal development. This process eliminates unwanted cells in a protective way. Recent evidence suggests that the failure of cells to undergo apoptosis may be involved in the pathogenesis of a variety of human diseases, including cancer, autoimmune diseases, and viral infections (reviewed by Steller, 1995; Thompson, 1995) . During hematopoiesis, the dierentiation and proliferation of various hematopoietic cells are dependent on certain hematopoietic growth factors. For example, hematopoietic progenitor cells are dependent on one or more colonystimulating factors (Metcalf, 1989; Williams et al., 1990; Koury and Bondurant, 1990) ; T lymphoblasts are interleukin-2 (IL-2)-dependent (Duke and Cohen, 1986) . Without these growth factors, the majority of these dependent cells die through apoptosis. It has been recently found that the capacity of human primary leukemic blasts to proliferate autonomously in vitro is associated with highly aggressive acute myeloid leukemia (Lowenberg et al., 1993) . This suggests that acquisition of autonomous growth of hematopoietic cells may be one important step leading to leukemogenesis.
GM-CSF and IL-3 are two hematopoietic cytokines produced by activated T cells and mast cells that are potent growth factors for multipotential hematopoietic progenitors as well as various other hematopoietic cells (Arai et al., 1990) . The high anity human receptors for GM-CSF, IL-3 and another cytokine IL-5 are composed of a shared common b subunit (bc subunit) and a distinct a subunit which is speci®c for each cytokine . While the a subunit determines the speci®city of the ligand binding, the bc subunit is largely responsible for signal transduction (Sakamaki et al., 1992) . Several intracellular signaling proteins are known to be activated once the GM-CSF/ IL-3 receptor is ligand-activated. These include induction of c-myc and c-fos/c-jun genes, activation of Jak2 kinase and tyrosine phosphorylation of other cellular proteins, and activation of the Ras, Raf, and MAP kinase pathway (Sato et al., 1993; Quelle et al., 1994) . Recent studies have shown that the proliferation and the anti-apoptotic function of IL-3/GM-CSF are mediated by two distinct pathways (Kinoshita et al., 1995; . It has been further suggested that the receptor-activated Ras/Raf/MAP kinase pathway is responsible for the anti-apoptotic eect of IL-3/ GM-CSF (Kinoshita et al., 1995) .
As a ®rst step to study the link between the autonomous (factor-independent) growth and leukemogenesis of hematopoietic cells, we have isolated and extensively characterized two non-autocrine variants derived from the GM-CSF-dependent, human hematopoietic progenitor cells (TF-1). In this report, we present data showing that either the activated Raf/ MAP kinase pathway in both variants is not sucient to repress the`twofold' death signals generated from the hybrids or that there is another mechanism that accounts for the factor-independent growth of these cells.
Results
TF-1 cells undergo apoptosis once their required cytokine (granulocyte-macrophage colony-stimulating factor, GM-CSF or interleukin-3, IL-3) is depleted from their normal growth medium . By culturing cells (10 8 ) in media lacking GM-CSF, four spontaneous variants (D2, D8, B6 and E9) were established. Surface marker analysis revealed no evidence that these variants were derived from or dierentiated into a dierent cell lineage (data not shown), and strongly suggested that they were all originated from the same TF-1 cells. However, due to the selection method that was employed in this study, we had no evidence that these four variants were truly independent clones.
In contrast to the wild-type cells, none of these variants underwent apoptosis upon cytokine-withdrawal (see below). Furthermore, under the same cytokine-free conditions they had a comparable DNA synthesis rate as that of the wild type cells maintained in a medium containing GM-CSF (data not shown). These variants, therefore, proliferated well in the absence of GM-CSF. The addition of GM-CSF did not further signi®cantly stimulate their growth ( Figure  1 ). The growth responses of all variants remained the same following one month's culture in GM-CSFcontaining medium (data not shown), suggesting that their genetic alteration(s) which rendered them insensitive to cytokine-withdrawal was very stable. To examine if any of these variants became autocrine growth, the following experiments were carried out. First, we examined if variant cells secreted any growth factors that could support the growth of wild type cells. As shown in Figure 1a , none of the conditioned medium sampled from the culture supernatant of variant cells supported the growth of the wild type cells. These results suggested that neither GM-CSF nor IL-3 was secreted by the variants. To further con®rm this, we examined if neutralizing antibody speci®c to GM-CSF or IL-3 would inhibit the growth of any of these variants. While anti-GM-CSF inhibited the growth of wild-type cells, it had no inhibitory eect on any of the variants (Figure 1b) . Similar results were obtained with anti-IL-3 antibody (data not shown). Taken together, these results suggest that the cytokineindependent growth of these variant cells is not due to their endogenous supply of GM-CSF or IL-3.
Another possibility that could generate a factorindependent variant was through the constitutive activation of those signaling molecules that would normally be activated upon ligand binding of the GM- Activation of the GM-CSF receptor b chain before and after GM-CSF stimulation. All cells were grown in cytokine-free medium for 20 h (7) prior to GM-CSF stimulation. Five minutes after stimulation (+), total cell lysates were prepared, immunoprecipitated with antibody speci®c to receptor b chain and the precipitated immunocomplexes were then analysed by immunoblot using anti-phosphotyrosine antibody (upper and middle panels). The same blot was stripped and reprobed with the antibody speci®c to the receptor b chain (lower panel). S and L denote results from the short and longer exposures, respectively CSF receptor. We examined this possibility by checking the activation state of some of these signaling molecules. Due to limit in resources and very similar growth properties between B6 and D2 and between E9 and D8 (data not shown), we only characterized D2 and D8 cells. We ®rst examined if the receptor b chain was activated in the absence of GM-CSF. As shown in Figure 2 , upon GM-CSF stimulation both variants had similar amounts of tyrosine-phosphorylated receptor b chain as the wild type cells even though they both expressed less amounts of the b-chain protein (compare lanes 2, 4 and 6). However, without ligand stimulation D2 cells had *1% of the b chain tyrosinephosphorylated (taking the ligand-stimulated amount as 100%), while D8 cells had only the background level of activated b-chain as did the wild-type cells (compare lanes 1, 3 and 5 in the ®lm exposed for a longer time). We next examined if the signalling proteins downstream of the receptor were aected in these two variants. As illustrated in Figure 3 , like TF-1 cells D2 and D8 had their Jak2 kinases tyrosine-phosphorylated Figure 4 Induction of nuclear proto-oncogenes by GM-CSF in TF-1, D2 and D8 cells. Cells were treated as described in the legend to Figure 2 . At various times (0.5 ± 6 h) after GM-CSF stimulation, total RNAs were prepared and analysed by Northern blotting. The same blot was sequentially probed with 32 P-labeled cDNA fragments speci®c to c-myc, Jun B, c-fos, c-jun and G3PDH (glyceraldehyde-3-phosphate dehydrogenase) genes, respectively. The ethidium bromide stained RNA gel (bottom panel) was included as a loading control only upon stimulation with GM-CSF (lanes 2, 4 and 6). Interestingly, in contrast to the negative result reported by (Quelle et al., 1994) , we consistently observed the tyrosine-phosphorylation of JAK1 upon GM-CSF stimulation of the TF-1 cells (Figure 3 ). This activation was also observed for D2 and D8 cells. However, in the absence of ligand stimulation only D2 had some activated forms of Jak1 (*1% of the ligandstimulated amount; compare lanes in D2 cells with or without GM-CSF).
We further examined if the immediate early genes known to be activated by the receptor were aected in these two variants. We found that in this case D8 behaved very similar to TF-1 cells with the induction levels and kinetics of c-myc, jun B, c-fos and c-jun by GM-CSF (Figure 4 , compares lanes 1 ± 5 to lanes 11 ± 15). Surprisingly, these genes were neither activated well by GM-CSF in D2 cells, nor did they express at a higher basal level when cells were depleted of GM-CSF (Figure 4 , compare lanes 1 and 6). Next we examined if the Ras/Raf/MAP kinase pathway shown to be important for the anti-apoptotic activity of GM-CSF was aected in these variants. As reported by others (Carroll et al., 1990; Okuda et al., 1992; Welham et al., 1992) , GM-CSF also activated Raf-1 and MAP kinases in TF-1 cells ( Figure 5 ). Upon GM-CSF stimulation approximately 30% of Raf-1 in TF-1 cells migrated slower in the SDS ± PAGE (lane 2) as indicative of the active forms (Morrison et al., 1988 (Morrison et al., , 1989 Kanakura et al., 1991) . However both variants without cytokine stimulation already had large amounts of active forms (D2: *50%; D8:495%; lanes 3 and 5). Stimulation of cells with GM-CSF further increased the percentage of Raf-1 migrated at a much slower position (480% in D2 and 100% in D8 cells; lanes 4 and 6). Consistent to this result, the MAP kinase, one downstream signalling protein of Raf-1 was also activated accordingly. Upon GM-CSF stimulation, MAP kinases (both p42 and p44 forms) were activated in TF-1 cells (lane 2). These activated forms of MAP kinases could be recognized by a phospho-speci®c MAP kinase antibody. Both D2 and D8 had some of their MAPKs in the activated forms when they were depleted of GM-CSF (lanes 3 and 5). Again, this activation was more prominent in D8 than in D2 cells. Stimulation of these cells with GM-CSF further increased the percentages of the activated forms (lanes 4 and 6) . Taken together, these data suggest that in the absence of GM-CSF the Raf/ MAP kinase pathway is already active in both D2 and D8 cells which may contribute to their survival in the cytokine-free medium.
Besides cytokine-depletion, u.v. irradiation, vaccinia virus infection, and TPA treatments could also induce apoptosis in TF-1 cells ( Figure 6a , lane 3; Figure 6b : lanes 3 ± 4; Figure 6c , lane 3). We next examined if these treatments could still induce apoptosis in D2 and D8 cells. As shown in Figure 6 , all three treatments induced apoptosis in both variants (Figure 6a : lanes 5 and 7; Figure 6b : lanes 6, 7, 9, 10; Figure 6c : lanes 6, 9). However, after TPA treatment the percentage of cells undergoing apoptosis was signi®cantly reduced in D2 but not in D8 cells (Figure 6 , compare 44.5% in D2 to 84.5% in TF-1 and 78.9% in D8 cells). The percentage of cells that attached to the culture¯asks and underwent dierentiation was accordingly increased ( Figure 6 , compare 55.5% in D2 to 15.5% and 21.1% in TF-1 and D8 cells, respectively).
We next examined if the resistance to cytokinedepletion induced apoptosis of these variants was a dominant or a recessive phenotype. To address this issue, cell fusion experiments were carried out. For this purpose, the wild-type and the variants (D2 and D8) were ®rst engineered to express a dominant selectable marker, neomycin (neo) and hygromycin(hyg) resistant genes, respectively. The resulting clones TF1(neo), D2(hygro) and D8(hygro) (see Materials and methods for generation of these clones) behaved very similar to their parental cells (see below). TF1(neo) were then fused to either D2(hygro) or D9(hygro) cells. The fused cells were selected by their ability to grow in medium containing both G418 and hygromycin. All cell hybrids (either as a single clone or as a mass culture) had twice the DNA contents of the unfused cells, and contained the expected near tetraploid set of chromosomes (data not shown). When these hybrids were grown in medium lacking GM-CSF, they, surprisingly like the wild type cells, underwent apoptosis as manifested by the fragmentation of their genomic DNA (Figure 7) . The degree of apoptosis was more prominent in TFD8 than in TFD2 hybrids (Figure 7 ).
Discussion
We have isolated and extensively characterized two nonautocrine, factor-independent variants from the GM-CSF dependent TF-1 cells. In the absence of GM-CSF, D2 had a minute amount of receptor b chain tyrosinephosphorylated and presumably activated. However, this amount of activated b-chain did not seem to transmit any mitogenic signal further into the nucleus, since its c-myc gene under cytokine-deprivation condi- We did, however, note that D2 but not D8 cells could easily proliferate in the de®ned medium lacking any serum (J-R Chao, unpublished result). This suggests that the basal activities of both receptor b chain and Jak1 may indeed play some role in the autonomous growth of the D2 cells. One common element to both D2 and D8 cells was that in the absence of cytokine stimulation both variants had some activated forms of Raf-1 and MAP kinases. The activation of Raf-1 kinase has been noted in a few factor-independent cells either derived spontaneously or by transfection of a cDNA encoding p210 BCR/ABL (Okuda et al., 1994) . Furthermore, Kinoshita et al. (1995) reported that the activated Ras/Raf/MAP kinase pathway by the ligand-activated receptor is likely to be responsible for the anti-apoptotic eect of GM-CSF. These results strongly suggest that the activated Raf-1 and MAP kinase observed in both variants may be responsible for their survival in the cytokine free medium. It is not clear what genetic alterations may have activated these two kinases. It may reside in the GM-CSF receptor itself thus activating the Raf/MAP kinase pathway but not other downstream signalling molecules as reported in previous studies (Sato et al., 1993; Inhorn et al., 1995) . Alternatively, the alteration may reside in other molecules known to activate the Raf/MAP kinase pathway. Regardless of the cause rendering Raf-1/MAP kinases constitutively active in these cells, this activation does not prevent these two kinases from being further activated by the GM-CSF signalling pathway.
The results of cell fusion were surprising. It showed that even the Raf-1/MAP kinase pathway was active in both variants, their hybrids with the wild-type cells were unexpectedly dependent on GM-CSF for their survival. Several possibilities may explain this result. First, the activated Raf-1/MAP kinase pathway derived from the variants may have been lost in the hybrids. Second, the activated Raf-1/MAP kinases in the hybrids may not be sucient to inhibit the`twofold' death signals that would come from both the wild-type and the variant cells upon cytokine deprivation. Third, the observed Raf-1/MAP kinase activation in these variants may not be the causal factor that leads them to be cytokine-independent. Instead, in both variants there may be a loss of function mutation lying close to the death machinery that makes them resistant to cytokine-deprivation induced apoptosis. Upon fusion to the wild type cells the death machinery is restored, and the hybrids subsequently exhibit the wild-type phenotype. Since both variants are still similar to the wild type cells susceptible to other apoptotic stimuli, this loss-offunction mutation, if it exists, is not likely to be the death executor itself. Further experiments are required to determine which possibility may actually account for the phenotype of these two variants.
Although D2 cells are still susceptible to TPA induced apoptosis, the percentage of cells that undergo this process is signi®cantly reduced (*40% decrease). It is not clear what other alterations(s) that D2 may have undergone and acquired this phenotype. Wang and Walsh (1996) have recently demonstrated that forced expression of the Cdk inhibitors p21 CIP1 or p16
INK4A can block apoptosis during myocyte differentiation. It is possible that the extra alteration(s) that D2 cells have acquired is linked to a process that is very similar to the overexpression of some CDK inhibitors in these cells. Alternatively, the decrease in TPA-induced apoptosis in D2 cell may be related to its ability to proliferate in de®ned medium without cytokine or serum. This additional survival advantage may increase the chance of cells undergoing TPAinduced dierentiation. Additional experiments will be required to con®rm these hypotheses. The cell hybrids are susceptible to apoptosis in the absence of GM-CSF. Cells were cultivated in medium with (+) or without (7) GM-CSF. Twenty-four hours after cultivation, the total genomic DNAs of these cells were isolated and analysed by 2% agarose gel electrophoresis. (a) and (b) show the results obtained from the parental, unfused cells and from the cell hybrids, respectively. M: 1 kb DNA marker
Materials and methods

Cell culture
TF-1 cells (Kitamura et al., 1989) were kindly provided by Dr Toshio Kitamura and were maintained in RPMI 1640 supplemented with 10% fetal bovine serum, 50 mM bmercaptoethanol, 2 mM L-glutamine, 100 m/ml penicillin G, 100 mg/ml streptomycin, and 1 ng/ml of GM-CSF. Human GM-CSF was kindly provided by Schering-Plough Ltd, Taiwan. Spontaneous cytokine-independent variants were selected by culturing TF-1 cells in the cytokine-free medium until the vast majority of cells were dead. This process occurred within 3 ± 4 days. After this stage, survival cells were individually cloned by limiting dilution in 96-well plates. Out of 10 8 cells, four variants were established. These variants (B2, D2, D8 and E9) were maintained in the same medium as that used for wild type cells except that GM-CSF was omitted.
Cell proliferation assay
Cells were cultured in the indicated growth medium at a density of 1610 5 cells/ml. Viable cell numbers were monitored daily by the trypan blue exclusion assay. Proliferation activity was measured by a colorimetric assay with MTT as a substrate, as described by Mosmann (1983) . In brief, 2610 4 cells were seeded in a 96-well plate and incubated for various times in the indicated medium. MTT (40 ml of 0.8 mg/ml) was added and the MTT reaction was allowed to proceed for 3 h. The purple reaction product was dissolved in 100 ml of DMSO and the proliferation activity was expressed as the absorption at 540 nm minus the background absorption at 650 nm as measured by a THERMOmax microplate reader (Molecular Devices, Menlo Park, CA).
DNA fragmentation assay
One million cells were collected following incubation in the desired medium for 24 h and analysed as previously described . Brie¯y, cell pellets were resuspended in 50 ml of Williams lysis buer (50 mM TrisHCl, pH 8.0, 10 mM EDTA, 0.5% Sarkosyl, and 500 mg/ml of proteinase K) and incubated at 508C for 3 h. Ten ml of RNase A (2 mg/ml) was then added to the lysates and the tubes were incubated for an additional hour. This lysate was mixed well with 1 ml of ethidium bromide (20 mg/ml), extracted once with an equal volume of phenol-chloroform (1 : 1), and stored at 48C after the addition of 20 ml of 1% low melting agarose solution containing 10 mM EDTA (pH 8.0). Samples were melted at 708C and allowed to solidify inside the well before electrophoresis was initiated.
Northern blotting
Total RNA was isolated from cultured cells using a method previously described (Liu et al., 1995) . Twenty mg of total RNA were resolved on a 1% formaldehyde-agarose gel and blotted onto a nitrocellulose ®lter using standard procedure. The blot was then probed sequentially with various [a-32 P]dCTP-labeled DNA fragments labeled to a speci®c activity of 1610 9 cpm/mg using random-priming method. After overnight hybridization at 428C using standard buer containing 50% formamide, the blot was washed once in 26SSC+0.1% SDS, twice in 0.26SSC+0.1% SDS at 558C and subjected to either autoradiography or direct quantitation using a phosphoImager.
Antibodies
Antibodies speci®c to JAK1, JAK2 and JAK3 were purchased from Santa Crutz Biotechnology; Anti-phosphotyrosine (clone 4G10) and anti-Raf-1 were from Upstate Biotechnology Incorporated, and Transduction Lab, respectively. Anti-phosph-speci®c MAPK was obtained from New England Biolabs.
Immunoprecipitation and Western blotting
Cells to be analysed were lysed in a buer containing 20 mM Tris-HCl, pH 7.4, 137 mM NaCl, 10% glycerol, 1% NP40, 2 mM sodium vanadate and 100 mM sodium uoride. Following lysis, cell extracts were precleared with protein A-sepharose and immunoprecipitated with a speci®c, primary antibody. The immunocomplexes were then resolved on a SDS-containing 8% polyacrylamide gel, transferred to polyvinylidene di¯uoride nylon membranes (Millipore), and analysed by probing the membrane either with anti-phosphotyrosine antibody or with antibodies speci®ed in the individual experiment. The speci®c bands were then visualized by ECL (enhanced chemiluminescence) Western blot system (Amersham).
Cell fusion
Cells to be fused were ®rst engineered to express a selectable marker (neomycin or hygromycin resistant gene) by infecting TF-1 or variants with retroviruses released from the PA317 packaging cells stably transfected with the pBABENeo or pBABEHygro retroviral vector (Morgenstem and Land, 1990) .The neomycin-resistant TF-1 and the hygromycin-resistant D2 and D8 cells were generated and designated as TF-1(Neo), D2(Hygro) and D8(Hygro), respectively. These cells were used as a mass culture of drug resistant pool. Fusion was subsequently carried out as follows. Brie¯y, one million of TF-1(Neo) and one million of D2(Hygro) or D8(Hygro) were pelleted together by centrifugation at 1000 r.p.m. for 5 min. The pellet was gently resuspended in 0.5 ml of polyethelene glycol (PEG, Merck PEG4000) for 2 min, diluted with one ml of RPMI for 5 min, then 5 ml of the same medium were added and the cells were centrifuged and resuspended in RPMI 1640 containing 10% and 1 ng/ml of GM-CSF7. Forty-eight hours later, G418 (500 mg/ml, GIBCO-BRL) and hygromycin (400 mg/ml, Calbiochem) were added to the cells to select the fused populations. These fused cells were analysed as a mass cell culture immediately after drug selection or as a single clone as indicated in the text. TFD2 (mix) and TFD8 (mix) are the mass cell cultures derived by fusing TF-1(neo) with D2(hyr) or with D8 (hyg), respectively. TFD2/B4, TFD8/D10, and TFD8/A11 are single clones selected from TFD2 (mix) or TFD8 (mix), respectively.
